Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are
leading candidates as red blood cell substitutes. In addition,
HBOCs are also potential oxygen therapeutics for treatment of
patients with critical ischemic conditions due to atherosclerosis,
diabetes and other conditions. This book will provide readers a
comprehensive review of topics involved in the HBOC development. It
focusses on current products and clinical applications as well as
on emerging technologies and future prospects.
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!